NCT05507853 Exploring Central Sensitization in Pregnant Women
| NCT ID | NCT05507853 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Göteborg University |
| Condition | Pelvic Girdle Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 144 participants |
| Start Date | 2023-08-15 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 144 participants in total. It began in 2023-08-15 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pelvic Girdle Pain (PGP) is reported by 50% of pregnant women and up to 11 years after pregnancy, 10% of women have persistent and per definition chronic PGP. Central (nervous system) sensitization that elicits pain hypersensitivity, may be one explanation. The overall aim of this study is to explore features of central sensitization in pregnant women and its predictive ability on physical activity, functioning and health in women with PGP. Measurements of central sensitization will be done on two study groups, pregnant women with PGP and healthy controls. To identify women at risk to develop chronic pain in relation to a common pain experience ie PGP in pregnancy, may help us understand if central sensitization early in life explains why women develop chronic pain.
Eligibility Criteria
Inclusion Criteria: * pregnant (first time pregnant or previous experience of pregnancy) * 18 years of age or older * have a single foetus pregnancy * be in gestational weeks 20-30 * able to read and understand Swedish or English Exclusion Criteria: * no history of a fracture or malignant disease in the back, pelvis, pelvic floor or hips * no systemic disease of the musculoskeletal or the nervous system * no diseases such as gestational diabetes or diabetes type 1 and 2, hypertension * no obstetric complications * no contradiction for tests.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05507853 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pelvic Girdle Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05507853 currently recruiting?
Yes, NCT05507853 is actively recruiting participants. Contact the research team at annelie.gutke@gu.se for enrollment information.
Where is the NCT05507853 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT05507853 clinical trial?
NCT05507853 is sponsored by Göteborg University. The trial plans to enroll 144 participants.